Stay updated with breaking news from Jonae Barnes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Presentations to Include New Antiviral Efficacy Results, Including SVR12 Data, from Lead-In Cohort of Ongoing Phase 2 HCV Trial Data Also Highlight the High Prevalence of Pre-Existing NS5A...
Presentations to Include New Antiviral Efficacy Results, Including SVR12 Data, from Lead-In Cohort of Ongoing Phase 2 HCV Trial Data Also H
Final Results Confirm 98% Sustained Virologic Response Rate at Week 4 Post-Treatment from Lead-in Cohort in Phase 2 HCV Study Enrollment in Phase 3 SUNRISE-3 Study Has Surpassed 1,400 COVID-19...
BOSTON, Feb. 21, 2024 -- Atea Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases,...
BOSTON, Jan. 03, 2024 -- Atea Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases,...